Calcium Channel Blocker Market Is Booming Across the Globe Explored in Latest Report 2020-2025 | Analysis by Key Players - Pfizer, Aventis, Searle, Bayer, AstraZeneca

The global Calcium Channel Blocker Market is thoroughly analysed by covering major segments of the market. An in-depth market segmentation is covered below that reflects the vital elements included in the Calcium Channel Blocker market research report. According to market is projected to grow at a stellar CAGR during the period of assessment, 2020-2024.

Global Calcium Channel Blocker Market overview:

The report of global Calcium Channel Blocker Market includes the competitive landscape section which provides the full and in-depth analysis of the current market trends, changing technologies and developments that will be beneficial for the companies, which are competing in the market. The report offers an overview of revenue, demand, and supply of data, futuristic cost, and growth analysis during the projected the year.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/254413

Calcium Channel Blocker which are also called calcium channel antagonists, or calcium antagonists, are most commonly used as antihypertensive drugs. Medication containing calcium channel blockers are utilized to control the blood pressure in patients who are suffering from hypertension. Calcium Channel Blocker are predominantly used to alter the heart rate, to reduce chest pain, and to prevent cerebral vasospasm.

Calcium Channel Blocker are highly effective as compared to beta blockers in lowering the risk of cardiovascular mortality. They help reduce the amount of calcium that goes into the cardiac muscle cells and cause them to relax. Changing lifestyle of people across all regions led to an increase in the number of stress related disease, which is a major factor, which in turn is anticipated to drive the calcium channel blocker market

The Global Calcium Channel Blocker Market is segmented on the basis of Product Type, Application, End Use Industry and Region. On the Basis of Product Type segment, the Calcium Channel Blocker Market is sub segmented into Dihydropyridine, Diltiazem, Verapamil. Based on End Use Industry segment, the Calcium Channel Blocker Market is sub segmented into Hypertension, Coronary Artery Disease, Arrhythmia, Cardiomyopathy.

Dihydropyridine is popularly known as calcium channel brokers. In pharmacology, dihydropyridine is called L-Type channel brokers. Dihydropyridine is utilized in the treatment of hypertension. Dihydropyridines have high vascular selectivity due to which, these drugs are primarily employed to control the arterial pressure and vascular resistance. This is the primary reason, dihydropyridine is used for hypertension treatment. Dihydropyridines includes various drugs such as felodipine, amlodipine, nimodipine, nitrendipine etc. The dihydropyridine drugs are very easy to identify as its drug names end with 'pine'. However, non-dihydropyridine results into more cardiac depression than dihydropyridine calcium channel blocker. Verapamil and diltiazem are two major drugs that belong to non-dihydropyridine CCBs, which are used clinically.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Leading players of the industry have also been profiled with their recent developments and other strategic industry activities. A few top players in the industry are Pfizer, Aventis, Searle, Bayer, AstraZeneca, Knoll Pharmaceuticals, Wyeth-Ayerst, AstraZeneca, Novartis, Sanofi.

Key Questions Answered in this Report:

1 What will the market size be in 2023?

2 What are the key factors driving the Global Calcium Channel Blocker Market?

3 What are the challenges to market growth?

�4 Who are the key players in the Global Calcium Channel Blocker Market?

�5 What are the market opportunities and threats faced by the key players?

Buy Calcium Channel Blocker Market analysis & forecast 2020-2024 Report along with complete TOC@ https://www.businessindustryreports.com/buy-now/254413/single

Latest Industry Updates:

Pfizer:- On the heels of the Institute of Medicine increasing the daily recommended intake of vitamin D to maintain bone health, Americans may be left wondering how to meet the new guidelines. Pfizer Consumer Healthcare, the makers of the 1 selling brand of calcium and vitamin D supplements, announces the launch of new Caltrate Soft Chews, a great-tasting and convenient way to help reach the new, higher daily vitamin D goals.

Specifically the new guidelines issued by the Institute of Medicine: Increased the daily vitamin D intake recommendation for adults up to 70 years of age from 200-400 IUs to 600 Ius.Increased the daily vitamin D intake recommendation for adults 71 years and older from 600 IUs to up to 800 Ius. Increased the daily upper intake level of vitamin D considered safe from 2,000 IUs to 4,000 IUs for adults

"Vitamin D is essential for calcium absorption and critical to overall health, but it is found in very few foods. To help fill the nutritional gaps and optimize calcium absorption, taking a supplement with vitamin D is recommended along with including vitamin D-fortified foods in your diet," says Michael F. Holick, Ph.D., MD, Professor of Medicine at Boston University Medical Center. "The Institute of Medicine's new recommendations reinforce the need to incorporate calcium and vitamin D3 into daily routines for bone health."

Caltrate Soft Chews are available in Chocolate Truffle and Vanilla Creme flavors and can be taken with or without food, offering a portable, nutritious and delicious solution to help get the daily calcium and vitamin D3 needed to stay healthy, active and moving. New Caltrate Soft Chews have 20 percent more essential calcium than Viactiv, and with 15 calories per chew, Caltrate Soft Chews can fit into most nutrition plans.

Calcium Channel Blocker Market: Region-wise Outlook

Asia Pacific was a prominent market for Calcium Channel Blockers in 2016. Among the countries in Asia Pacific, the demand was substantially high in developing countries such as China and India. These countries have been witnessing rapid increase in its population along with expansion of their overall economies, which has led to increase in disposable income. Increased spending on home interiors is fuelling the Calcium Channel Blocker market in Asia Pacific.

There are several manufacturers of Calcium Channel Blockers in Europe and North America. In North America, the demand for Calcium Channel Blockers is primarily driven by the residential sector. Improved standards of living and rising usage of Calcium Channel Blockers for flooring purpose are anticipated to drive the market in North America.

In Europe, the demand for Calcium Channel Blocker is anticipated to be primarily from the commercial sector. Calcium Channel Blockers are being employed widely for flooring in commercial complexes, which is estimated be a major factor that is likely to propelling the consistent expansion of the Calcium Channel Blocker market in the region.

Demand for Calcium Channel Blockers in Middle East & Africa is projected be primarily due to the utilization of Calcium Channel Blockers in the construction industry. In recent years, there has been exceptional growth in the construction industry of UAE and Egypt which has driven the market of Calcium Channel Blockers in the region of Middle East & Africa

Grab Your Report at an Impressive Discount @ �https://www.businessindustryreports.com/check-discount/254413

Table of Contents:

Global Calcium Channel Blocker Market Report 2020

1 Calcium Channel Blocker Definition

2 Global Calcium Channel Blocker Market Major Player Share and Market Overview

3 Major Player Calcium Channel Blocker Business Introduction

4 Global Calcium Channel Blocker Market Segmentation (Region Level)

5 Global Calcium Channel Blocker Market Segmentation (Product Type Level)

6 Global Calcium Channel Blocker Market Segmentation (Industry Level)

7 Global Calcium Channel Blocker Market Segmentation (Channel Level)

................... Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune - India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.